Duato discusses the split of the business, dealing with the scrutiny brought about by lawsuits, and 2025 priorities.

AbbVie’s Skyrizi was responsible for the highest TV advertising outlay in pharma in most months of 2024, but 2025 is starting ...

The healthcare leader is also an excellent income stock. Johnson & Johnson has increased its dividend payout for 62 ...

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...

Tech entrepreneur and longevity advocate Bryan Johnson has discontinued his use of rapamycin, a controversial anti-ageing ...

The Spokane County Medical Examiner says Rob Johnson was found dead in an apartment fire, but his death was caused by ...

Johnson & Johnson is normally a good buy for its dividend and the stability it offers. Over the past five years, however, the ...

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...

The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often ...

B Health and two safety-net hospitals want to help the government prove that drugmakers are required to give upfront ...

A man accused of killing a 19-year-old man while attempting to rob him during a drug deal in 2023 began his trial Tuesday. Jayveon Johnson, 23, is accused in the fatal shooting of David Rezentes.

Johnson & Johnson's financial results are generally ... a new law in the U.S. that gives Medicare the power to negotiate drug prices. The first round of negotiations will target three of the ...